Sunshine Biopharma (SBFM) EBIAT (2016 - 2025)
Historic EBIAT for Sunshine Biopharma (SBFM) over the last 14 years, with Q3 2025 value amounting to -$883820.0.
- Sunshine Biopharma's EBIAT rose 2621.32% to -$883820.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.0 million, marking a year-over-year decrease of 4180.64%. This contributed to the annual value of -$5.1 million for FY2024, which is 1393.84% down from last year.
- Per Sunshine Biopharma's latest filing, its EBIAT stood at -$883820.0 for Q3 2025, which was up 2621.32% from -$1.8 million recorded in Q2 2025.
- Over the past 5 years, Sunshine Biopharma's EBIAT peaked at $667116.0 during Q4 2021, and registered a low of -$23.5 million during Q4 2022.
- In the last 5 years, Sunshine Biopharma's EBIAT had a median value of -$1.3 million in 2023 and averaged -$2.8 million.
- Examining YoY changes over the last 5 years, Sunshine Biopharma's EBIAT showed a top increase of 16155.38% in 2021 and a maximum decrease of 646184.13% in 2021.
- Quarter analysis of 5 years shows Sunshine Biopharma's EBIAT stood at $667116.0 in 2021, then crashed by 3624.47% to -$23.5 million in 2022, then skyrocketed by 94.68% to -$1.3 million in 2023, then crashed by 72.65% to -$2.2 million in 2024, then surged by 59.05% to -$883820.0 in 2025.
- Its last three reported values are -$883820.0 in Q3 2025, -$1.8 million for Q2 2025, and -$1.2 million during Q1 2025.